The World’s Foremost Source of Medicinal Product Information
Accurate medicinal product information – quickly and correctly communicated – is vital for many organizations active in life sciences – both commercial and regulatory agencies. The Uppsala Monitoring Centre (UMC) is today the first-choice source of medicinal product information for both user groups – a global hub of products, services and scientific research focused on clinical data and patient safety.
The unique codes and classifications of our flagship product – the WHO Drug Dictionary Enhanced (WHO DDE) – assist Pharmaceutical Companies and CROs to set up clinical studies, interpret concomitant medication, analyze the data, and submit the results.
Our VigiBase™ database of more than seven million adverse reaction reports gathered from over 100 countries is the world’s largest collection of drug safety information.
WHO-ART (WHO Adverse Reaction Terminology) helps WHO Program member countries and commercial groups code clinical information in relation to drug therapy.